Skip to main content
logo
Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea flag South Korea · Delayed Price · Currency is KRW
130,300
+3,700 (2.92%)
At close: Feb 27, 2026

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Biotechnology
20.91B135.42B75.92M
Biotechnology Growth
-84.56%178270.49%-
Total
20.91B135.42B75.92M
Total Growth
-84.56%178270.49%-

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Korea
--75.92M
United States
20.91B135.42B-
United States Growth
-84.56%--
Total
20.91B135.42B75.92M
Total Growth
-84.56%178270.49%-
Source: S&P Global Market Intelligence.